Development and validation of phosphonate-based inhibitors and activity-based probes (ABPs) for detection and pharmacological targeting of kallikreins
The generation of a novel activity-based probe (ABP) and inhibitor specific for kallikrein 7 (KLK7) and validation of its therapeutic effects in vivo is described here. KLK7 is a protease with well-established functions in skin inflammation and overdesquamation and in cancer. ABPs, on the other hand...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10889/15718 |